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Abstract Thrombopoietin (Tpo) is a cytokine regulating 
megakaryocyte maturation and platelet formation. We studied 
Tpo-induced signal transduction, and found that Tpo induces 
phosphorylation of adapter molecules Shc and Vav, and of serine/ 
threonine kinases Raf-I and mitogen-activated protein (MAP) 
kinases. Further, Tpo induced activation of Ras, MAP kinase 
kinase, MAP kinase and Pim-l. Taken together with other obser- 
vations, we concluded that Tpo induces the activation of at least 
two distinct signaling pathways, a specific Tyk2-JAK21STAT1- 
STAT3-STAT5 signaling cascade and a common Shc/Vav/Rasl 
Raf-lfMAP kinase kinaselMAP kinase signaling cascade. 
Key words. Thrombopoietin; She; Vav; Ras: Raf-l :  
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1. Introduction 
Thrombopoietin (Tpo) was recently identified as a specific 
cytokine, that regulates megakaryocytopoiesis and platelet for- 
mation [1-5]. The JAK kinases and STAT proteins play a 
critical role in Tpo signal transduction [(~8, Nagata et al., 
unpublished results]. In addition to JAK-STAT signaling path- 
ways, however, cytokines induce activation of a variety of sig- 
naling molecules: serine/threonine kinases Raf- l ,  Pim-1, mito- 
gen-activated protein (MAP) kinases and MAP kinase kinase. 
SH2 adapter molecules Shc, Grb2 and Vav, GTP-binding pro- 
tein Ras, protein kinase C-regulating enzymes, phosphatidyli- 
nositol 3-kinase and phospholipase C 7, and tyrosine kinases 
other than JAK kinase family Fes/Fps, Lck, Lyn and Fyn. 
These observations suggested that the binding of a cytokine to 
the receptor induces activation of multiple signaling cascades 
which cross-talk with each other. Little has been reported about 
activation of these classical signaling factors in the Tpo-stimu- 
lated signaling cascade. We examined which of these signaling 
factors are actually activated upon Tpo stimulation in Tpo- 
dependent FD-TPO cells [9], and found that the binding of Tpo 
to the receptor induces phosphorylation of a Shc and Vav, and 
activation of Ras, Raf-1. MAP kinase kinase and MAP kinase. 
but we failed to observe activation of tyrosine kinases other 
than JAK family. We discuss the role of this common signaling 
cascade. 
2. Materials and methods 
2.1. Tpo, antibodies and cell culture 
Mouse Tpo cDNA in pMEI8 was transfected into African green 
monkey kidney COS-7 cells, and stable transfectants resistant to anti- 
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biotic G418 (1 mg/ml) were obtained. COS-7 transfectants expressing 
Tpo were maintained in DME medium supplemented with 10% fetal 
calf serum. Conditioned media containing mouse Tpo were prepared 
by culturing the cells for 2.5 days without fetal calf serum. A mock- 
transfected COS-7 cell supernatant was also prepared. Tpo-dependent 
mouse FD-TPO cells [9] were cultured in RPMI 1640 medium supple- 
mented with 10% fetal calf serum and 50 units/ml of Tpo. Polyclonal 
rabbit antibody against mouse Shc and mouse Pim-1 kinase, and mouse 
monoclonal antibody against phosphotyrosine (4G10) were purchased 
from Upstate Biotechnology Inc. (Lake Placid, NY). Polyclonal rabbit 
antibody against mouse Raf-I (C-12), and mouse Vav (C-14) were 
obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Monoclo- 
nal anti-Ras antibody Y13-259 was from Oncogene Science, Inc. 
(Uniondale, NY). Mouse monoclonal antibody against MAP kinase 
(Z033) was from Zymed Laboratories (South San Francisco, CA). 
2.2. Imrnunoprecipitation and immunoblotting 
FD-TPO cells were starved in medium containing 0.4% fetal calf 
serum, 0.125 mg/ml of transferrin and 0.01% BSA without Tpo for 12 
h, and restimulated with or without 50 units/ml of Tpo for 20 rain in 
the presence of 0.7 mM sodium orthovanadate. The stimulated and 
unstimulated cells were immediately sed in a lysis buffer (0.5% Non- 
idet P-40, 150 mM NaC1, 2 mM sodium orthovanadate, 100 mM so- 
dium fluoride. 10 mM sodium pyrophosphate, 1 mM EDTA, 50 mM 
Tris-HCl, pH 7.5, 2 mM Pefabloc, 10 ng/ml leupeptin and 10 ng/ml 
aprotinin). Insoluble material was then removed by centrifugation a d 
the clarified cell lysate was incubated with a specific antibody at 4°C 
for 2 h. The immunocomplexes were then bound to protein A-Sepha- 
rose at 4°C for 1 h. The beads were washed 5 times with lysis buffer 
containing 0.1% Nonidet P-40 before being boiled in Laemmli sample 
buffer. Samples were fractionated in 7-12% SDS-polyacrylamide g ls 
and electrotransfered to ECL membrane (Amersham). The membrane 
was blocked in 5% BSA in 20 mM Tris-HC1, pH 7.5, 150 mM NaC1 
and 0.5% Tween 20 (TBS-T), and incubated with anti-phosphotyrosine 
antibody (4GI0) for 2 h. After washing 3 times with TBS-T, the mem- 
brane was incubated with anti-mouse IgG conjugated horseradish per- 
oxidase antibody, and the antibody complexes were visualized by ECL 
(Amersham). To reprobe the membranes with another antibody, the 
membranes were washed in the stripping buffer (100 mM fl-mercap- 
toethanol, 2% SDS, 62.5 mM Tris-HCl, pH6.7) at 50°C for 30 min, and 
blocked with BSA. 
2.3. Labeling o! eel& with [~':P]orthophosphate 
FD-TPO cells (1 x 107) were starved in RPMI 1640 medium with 
0.4% BSA for 10 h, and washed with phosphate-fi'ee RPMI medium 
containing 0.4% BSA and 0.5 mM sodium orthovanadate. The cells 
were incubated for an additional 2h in 1 ml of this medium containing 
1.0 mCi of carrier-free [32p]orthophosphate (Amersham). Labeled cells 
were cultured with or without Tpo for an additional 7 rain and lysed. 
Cell lysates prepared were normalized for protein content. Immunopre- 
cipitation was performed as described above and the precipitated pro- 
teins were resolved by 7.5% SDS-PAGE and autoradiography. 
2.4. Assay oj Ras activation 
Ras activity was assayed by measuring uanine nucleotides bound 
to Ras by the modified method of Downward et al. [10]. FD-TPO cells 
were labeled with [32P]orthophosphate, and incubated with or without 
50 units/ml of Tpo for 7 rain. Cells were lysed by lysis buffer (20 mM 
Tris-HCl, pH 7.5, 20 mM magnesium chloride, 150 mM sodium chlo- 
ride, 0.5% Triton X-100, 20¢tg/ml aprotinin, and 1 mM sodium ortho- 
vanadate). Ras was immunoprecipitated with the anti-Ras-specific 
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monoclonal antibody Y13-259 precoupled to protein A agarose by 
rabbit anti-rat IgG, and washed. The bound nucleotides were eluted by 
incubating at 65°C for 5 min in 20 mM Tris-HC1, pH 7.5, 1 mM GTR 
I mM GDR 20 mM EDTA and 2% SDS, and separated by thin layer 
chromatography on PEI-cellulose plates in 0.75 M potassium phos- 
phate buffer (pH 3.4). Nuclcotides were visualized by autoradiography, 
and GDP and GTP standards were visualized by UV light at 286 nm. 
2.5. MAP kinase assay 
Cell lysates (30 pg/lane) were applied onto 12% micro-SDS-poly- 
acrylamide gels containing 0.5 mg/ml bovine brain myelin basic protein 
(MBP) as a substrate for MAP kinases. After electrophoresis, the gels 
were soaked sequentially: in 20% isopropanol in 50 mM Tris-HC1, pH 
8.0 for 1 h; in 5 mM/~-mercaptoethanol i  50 mM Tris-HCl, pH 8.0 
(Solution A) for 1 h; in 6 M guanidine/HCl in Solution A for I h; in 
0.04% Tween 40 in Solution A for 16 h; and in 40 mM Hepes-NaOH, 
pH 7.5, 2 mM dithiothreitol, 0.1 mM EGTA, 15 mM MgCI 2 for 30 rain. 
MAP kinase assays were then performed by adding 25/,tM ATP (25/,/Ci 
[y-32p]ATP/10 ml) at room temperature for 1 h. The gels were washed 
in 5% trichloroacetic a id solution containing 1% pyrophosphate until 
the background radioactivity reached almost zero, then dried, and 
autoradiographed. 
2.6. MAP kinase kinase assz O" 
MAP kinase kinase activity was measured by the method of Matsuda 
et al. [11]. Briefly, cell extracts were applied onto DEAE-cellulosc, and 
the flow-through fractions were assayed for MAP kinase kinase activity 
by incubating bacterially expressed inactive Xenopus MAP kinase and 
50pM [y-32P]ATP in 20 mM Tris-HC1, pH 7.5, 15 mM MgClz and 2 
mM EGTA at 20°C for 30 min. The phosphorylated substrates were 
applied onto 15% SDS-polyacrylamide geland visualized by autoradi- 
ography. 
3. Results 
3.1. Tpo induces phosphorylation of  SH2 adapter molecule She 
Shc is an SH2-containing adapter protein which is tyrosine 
phosphorylated by various growth stimulations and is believed 
to mediate a signal from the receptor to Ras activation [12]. To 
test the possibility that Shc is involved in Tpo-mediated signal 
transduction, we examined tyrosine-phosphorylation f She 
after Tpo stimulation. Anti-Shc antibody immunoprecipitated 
50 and 56 kDa Shc proteins from FD-TPO cells (Fig. 1A, right 
panel), and immunoblotting with anti-phosphotyrosine anti- 
body revealed that these Shc proteins were clearly tyrosine- 
phosphorylated in response to Tpo (Fig. IA, left panel). The 
major band between 50 kDa and 56 kDa is due to the heavy 
chain of the first antibody used for immunoprecipitation. 
3.2. Vav is tyrosine-phosphorylated by Tpo 
The hematopoietic-specific c-vav proto-oncogene product, 
Vav, possesses an SH2 domain and two SH3 domains, which 
implies that Vav is involved in tyrosine kinase-mediated signal- 
ing pathway [13]. To examine the possible involvement of Vav 
___) 
Fig. 1. Tyrosine-phosphorylation of SH2 adapter molecules She and 
Vav upon Tpo stimulation. (A) Tyrosine-phosphorylation of Shc. lm- 
munoprecipitated Shc form FD-TPO cells stimulated with (+) or with- 
out (-) Tpo was immunoblotted with anti-phosphotyrosine antibody 
(left two lanes) and with anti-Shc antibody (right two lanes), p56 and 
p50 indicate the immunoprecipitated Shc. The major band between 50 
kDa and 56 kDa is the heavy chain of the first antibody used lbr 
immunoprecipitation. (B) Tyrosine-phosphorylation of Vav. Vav was 
immunoprecipitated from FD-TPO cells stimulated with (+) or without 
(-) Tpo, and probed with anti-phosphotyrosine antibody (left two 
lanes) and with anti-Vav antibody (right lwo lanes), p95 indicates 
phosphorylated Vav. 
during Tpo receptor-mediated signal transduction, FD-TPO 
cells were stimulated with or without Tpo, and the immunopre- 
cipitates of anti-Vav antibody were probed with anti- 
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Fig. 2. Activation of Ras by Tpo stimulation. Ras was immunoprecip- 
itated from 32p-labeled FD-TPO cell lysates with anti-Ras antibody• 
The nucleotides bound to Ras were e|uted and separated by thin-layer 
chromatography. Radioactivities of GDP and GTP bound to Ras were 
quantified, and the ratios (%) of Ras-GTP/Ras-GDP +Ras-GTP are 
shown. Values are averages of three independent experiments• 
phosphotyrosine antibody• Fig. I B, left panel, clearly shows 
that Tpo induced tyrosine phosphorylation of Vav (p95). By 
reprobing the same blots with anti-Vav antibody (Fig. 1 B, right 
panel), it was confirmed that the degree of tyrosine phosphoryl- 
ation depends upon Tpo stimulation but not on the amounts 
of the immunoprecipitated Vav. These results indicate that Vav 
is phosphorylated on its tyrosine residues in response to Tpo 
stimulation. 
3.3. Activation of Ras by Tpo stimulation 
The GTP binding protein, Ras, is involved in a variety of 
signal transduction pathways [14]. Its activity is regulated by 
bound guanine nucleotide. The GDP-bound Ras is inactive. 
whereas the GTP-bound Ras is active. External signals increase 
the GTP-bound Ras by either stimulating the exchange of G DP 
with GTP or inhibiting the Ras GTPase activating protein 
(GAP). To examine if FD-TPO cells could activate Ras in 
response to Tpo, FD-TPO cells labeled with [32p]ortho- 
phosphate were stimulated with or without Tpo, and the ratio 
(%) of Ras-GTP/Ras-GDP + Ras-GTP were measured• Tpo 
stimulated the formation of active Ras-GTP form over inactive 
Ras-GDP form (Fig. 2), and the Ras-GTP form increased in 
1 min and peaked in 5 10 rain after stimulation (data not 
shown), indicating that Ras can be activated by Tpo stimula- 
tion. 
3.4. RaJ:l is phosphorylated b),Tpo 
A serine/threonine kinase, Raf-1, which specifically associ- 
ates with activated Ras and MAP kinase kinase [15,16], can be 
phosphorylated on its tyrosine and serine residues. To examine 
the possibility that Raf-1 is phosphorylated byTpo stimulatiom 
cell lysates timulated with or without Tpo were examined for 
a change in the mobility of Raf-1 by immunoblotting analysis 
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using an anti-Raf-l-specific antibody (Fig. 3A). In untreated 
cells, the mobility of Raf-I was characteristic of its 
unphosphorylated state (Fig. 3A, left lane). After Tpo stimula- 
tion, Raf-1 was largely retarded (shown as p74) (Fig. 3A, right 
lane), suggesting that Raf-1 is phosphorylated. Furthermore, 
cells were labeled with [32p]orthophosphate in vivo, stimulated 
with or without Tpo, and Raf-1 was immunoprecipitated by 
anti-Raf-1 antibody. Fig. 3B shows that Raf-1 (p74) was weakly 
but definitely phosphorylated upon Tpo stimulation, indicating 
that the shift in Raf-1 mobility is due to phosphorylation. 
3•5. Activation of MAP kinase kinase and MAP kinase by Tpo 
stimulation 
The activity of MAP kinase kinase, which regulates MAP 
kinases and is the convergence point of various signals [17] was 
measured. As shown in Fig. 4A, MAP kinase kinase prepared 
from Tpo-stimulated cells clearly phosphorylated Xenopus 
MAP kinase, while one from unstimulated cells did not, indicat- 
ing that a Tpo-mediated signal significantly stimulated MAP 
kinase kinase activity. 
MAP kinase can be activated by tyrosine and threonine 
phosphorylation through MAP kinase kinase and Raf-1 kinase 
[17]. Cell extracts timulated with or without Tpo were probed 
with anti-MAP kinase antibody, which reacts with both ERK1 
and ERK2. As shown in Fig. 4B, right panel, both 
phosphorylated ERK1 (pERK1) and phosphorylated ERK2 
(pERK2) were clearly detected above the unphosphorylated 
forms in ceils stimulated with Tpo, but not in cells without Tpo. 
Reprobing the same blots with anti-phosphotyrosine a tibody 
confirmed that both pERK1 and pERK2 were tyrosine- 
phosphorylated (Fig. 4B, left panel). 
We next examined whether MAP kinase is actually activated 
by Tpo, by using the kinase detection assay within gels contain- 
ing MBP. It was found that MAP kinase activity was strikingly 
high in Tpo-stimulated cells (Fig. 4C), while little enzyme activ- 
ity was detected in cells without Tpo. MAP kinase activity 
increased in 2 rain and peaked in 5-10 min after Tpo stimula- 
lion (data not shown). Thus, it was concluded that Tpo mark- 
edly stimulates the phosphorylation f both ERK1 and ERK2, 
and that MAP kinase cascade is activated by Tpo. 
3•6• Induction of Pim-1 kinase expression by Tpo stimulation 
The pim-1 proto-oncogene encodes a 38 kDa cytoplasmic 
A B 
TpO' - -  + 
7s-  
~ ~ ~-p74 
Tpo:  - + 
kDa, 
118 _1 
78- ~ 4.- p74 
Fig. 3. Phosphorylation f Raf-1 by Tpo stimulation. (A) Mobility shift 
of Raf- 1 after Tpo stimulation. Raf- 1 was immunoprecipitated from the 
FD-TPO cell lysates timulated with (+) or without (-) Tpo, applied 
onto SDS-PAGE, and immunoblotted with the same antibody, p74 
indicates mobility shifted Raf-l. (B) Phosphorylation f Raf-1. Cells 
were labeled with [32P]orthophosphate, stimulated with (+) or without 
(-) Tpo, and Raf-1 (p74) was immunoprecipitated with anti-Raf-1 
antibody• Samples were analyzed by SDS-PAGE and autoradio- 
graphed. 
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Fig. 4. Activation of MAP kinase kinase and MAP kinase by Tpo 
receptor-mediated signal. (A) Activation of MAP kinase kinase by Tpo. 
FD-TPO cells were stimulated with (+1 or without (-) Tpo, and cell 
extracts were assayed for MAP kinase kinase activity after chromatog- 
raphy on DEAE-cellulose. The activity was measured by the ability to 
phosphorylate recombinant inactive MAP kinase. (B) Tyrosine-phos- 
phorylation of MAP kinase. Cells were stimulated with (+1 or without 
(-) Tpo, and MAP kinases were immunoblotted with anti-MAP kinase 
(ERK1 and ERK2)-specific antibody (right panel), and reprobed with 
anti-phosphotyrosine antibody (left panel). (C) MAP kinase is activated 
by Tpo. MAP kinase assay of the cells stimulated with (+) or without 
(-) Tpo. MAP kinase activity was measured by the kinase detection 
assay within gels containing bovine MBE 
serine/threonine kinase which is expressed in hematopoietic 
cells [18]. As shown in Fig. 5, immunoblot analysis of total cell 
lysates with anti-Pim-1 kinase antibody revealed that the 
amounts of Pim-1 kinase (p38) significantly increased in 4 h 
after Tpo stimulation i  FD-TPO cells. Thus, it was concluded 
that Tpo receptor-mediated signal induces expression of Pim- 1 
kinase. 
4. Discussion 
It has been described that Tpo induces the activation of two 
JAK kinases, JAK2 and Tyk2, and three STAT proteins, 
STAT1, STAT3 and STAT5 [24- 26, Nagata et al., unpublished 
results]. Furthermore, we reported that the Tpo receptor-medi- 
ated lineage-specific signals activate the expression of GATA-I 
and NF-E2 genes, and consequently induce expression of the 
megakaryocyte/platelet-specific cell surface antigens including 
GPIIIa and the Pm- 1 recognized antigen [9]. We therefore con- 
cluded that the binding of Tpo to its receptor esults in the 
activation of at least two distinct signaling pathways, a com- 
mon Shc-Vav-Ras-Raf-l-MAP kinase kinase-MAP kinase sig- 
naling cascade and a specific JAK-STAT signaling cascade, as 
well as a lineage-specific signaling cascade. 
Although Tpo receptor lacks tyrosine kinase domains, the 
binding of Tpo to its receptor induced tyrosine and serine/ 
threonine phosphorylation of various cellular target proteins. 
Tec-related kinases (Tec, Btk and Itk) are expressed in various 
hematopoietic cells [19], and are phosphorylated by IL3, stem 
cell factor and IL6. Syk kinase is also abundantly expressed in
mature platelets, and plays an important role in platelet-specific 
functions [20]. The JAK kinase family might not be the only 
tyrosine kinase regulating Tpo receptor-mediated signals. 
Therefore, we examined the possible involvement of Tec kinase 
and Syk kinase in Tpo receptor-mediated signaling pathways. 
In our hands, however, we failed to detect yrosine-phosphoryl- 
ation of either Tec kinase or Syk kinase (data not shown), 
although they are expressed in FD-TPO cells. We cannot ex- 
clude the possibility that Tec and Syk kinases are involved in 
Tpo signaling cascades, but they are, at least, not major tyro° 
sine-phosphorylated proteins in FD-TPO cells. 
The protein kinase C cascade might be also activated through 
phosphatidylinositol-3 kinase and phospholipase C7, which 
may finally result in c-myc activation. While we detected the 
expression of both phosphatidylinositol-3 kinase and phospho- 
lipase C 7 in FD-TPO cells, we failed to detect phosphorylation 
of these enzymes even after Tpo-stimulation. This may be due 
to the weak phosphorylation a d/or the antibodies used here, 
but our result is consistent with a report of Drachman et al. [6] 
Tpo: 
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Fig. 5. Induction of Pim-1. FD-TPO cells were stimulated with (+) or 
without (-) Tpo for 4 h, and total cell lysates were immunoblotted with 
anti-Pim-1 antibody. 
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that also failed to see the phosphorylation fphosphatidylinos- 
itol 3-kinase and phospholipase Cy in BaF3 cells expressing 
exogenous Mpl. 
Vav is known to contain an SH2 domain and two SH3 do- 
mains [13]. Very recently, it was found that the SH2 domain in 
Vav is constitutively associated with JAK kinases [21], and that 
the amino terminal SH3 in Vav constitutively binds to Grb2 
[22,23]. It is still controversial, however, whether Vav functions 
as a guanine xchange factor for Ras or Ras-related proteins 
Rac and Rho. This makes it essential to clarify the role of Vav 
in mitogenesis and cytokine receptor signaling in hematopoietic 
cells, although it is evident hat Vav acts on the signaling path- 
way from the receptor to Ras activation. 
There must be Tpo-specific signaling cascades for determin- 
ing the cell fate of megakaryocytes, and for triggering the pol- 
yploidization and platelet release. Nothing is known about 
what determines megakaryocyte specificity, and what is the 
difference between erythroid and megakaryocyte in differentia- 
tion signals and in transcription factors. These problems await 
resolution. 
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